COVID-19FinancialRegulatory

US Preps For ‘COVID-19 Mass Vaccination’ With $110 Million Spent On Needles And Syringes

May 4, 2020 / Thomas Brewster, Forbes Staff

The U.S. government is getting its vaccine supplies ready in anticipation of a working cure. Two separate orders signed off on May 1, 2020, total $100 million and specify needles and syringes “for a COVID-19 Mass Vaccination Campaign.”

One $27.5 million order went to Colorado-based Marathon Medical, the other $83.7 million to Texan business Retractable Technologies. The orders were placed by the Health and Human Services (HHS) department’s Office of the Assistant Secretary for Preparedness and Response (ASPR).

The orders come as a raft of different vaccines are under development and testing. The U.S. government has backed a handful, including a $450 million deal with Johnson & Johnson arm Janssen Pharmaceutical for its COVID-19 cure. That vaccine could be ready by early 2021.

READ THE REST HERE

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button